CYNTHIA A. HEINLEIN ET AL: "Androgen Receptor in Prostate Cancer", ENDOCRINE REVIEWS, vol. 25, no. 2, 1 April 2004 (2004-04-01), pages 276-308, XP055541038, US ISSN: 0163-769X, DOI: 10.1210/er.2002-0032 (B1)

DAVID OLMOS ET AL: "Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study", LANCET ONCOLOGY, vol. 13, no. 11, 1 November 2012 (2012-11-01), page 1114, XP055284539, GB ISSN: 1470-2045, DOI: 10.1016/S1470-2045(12)70372-8 (B1)

EDWARDS S ET AL: "Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer", BRITISH JOURNAL OF CANCER, NATURE PUBLISHING GROUP, GB, vol. 92, no. 2, 31 January 2005 (2005-01-31), pages 376-381, XP002341218, ISSN: 0007-0920, DOI: 10.1038/SJ.BJC.6602261 (B1)

EDWIN E REYES ET AL: "Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer", 26 November 2014 (2014-11-26), JOURNAL OF TRANSLATIONAL MEDICINE, BIOMED CENTRAL, PAGE(S) 1 - 15, XP021206180, ISSN: 1479-5876 (B1)

EDWIN E REYES ET AL: "Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer", JOURNAL OF TRANSLATIONAL MEDICINE, BIOMED CENTRAL, vol. 12, no. 313, 26 November 2014 (2014-11-26), pages 1-15, XP021206180, ISSN: 1479-5876, DOI: 10.1186/S12967-014-0313-Z (B1)

Kathryn L. Penney ET AL: "mRNA Expression Signature of Gleason Grade Predicts Lethal Prostate Cancer", JOURNAL OF CLINICAL ONCOLOGY, vol. 29, no. 17, 10 June 2011 (2011-06-10) , pages 2391-2396, XP055390709, US ISSN: 0732-183X, DOI: 10.1200/JCO.2010.32.6421 (B1)

ZHIYONG GUO ET AL: "A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion?Resistant Growth", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 69, no. 6, 24 February 2009 (2009-02-24), pages 2305-2313, XP008154820, ISSN: 0008-5472, DOI: 10.1158/0008-5472.CAN-08-3795 [retrieved on 2009-02-24] (B1)

MH EILEEN TAN ET AL: "Androgen receptor: structure, role in prostate cancer and drug discovery", ACTA PHARMACOLOGICA SINICA, vol. 36, no. 1, 1 January 2015 (2015-01-01), pages 3-23, XP055541034, GB ISSN: 1671-4083, DOI: 10.1038/aps.2014.18 (B1)

R W ROSS ET AL: "Sensitivity and specificity of a whole-blood RNA transcript-based diagnostic test for the diagnosis of prostate cancer (CaP) compared with prostate-specific antigen (PSA) alone", 2009 ASCO ANNUAL M EETING, 1 January 2009 (2009-01-01), XP055284520, (B1)

Thea Grindstad ET AL: "High Progesterone Receptor Expression in Prostate Cancer Is Associated with Clinical Failure", PLOS ONE, vol. 10, no. 2, 27 February 2015 (2015-02-27), page e0116691, XP055659631, DOI: 10.1371/journal.pone.0116691 (B1)

WO-A1-2014/028925 (B1)

WO-A2-2009/128936 (B1)

WO-A2-2014/151290 (B1)

Laia Agell ET AL: "A 12-Gene Expression Signature Is Associated with Aggressive Histological in Prostate Cancer", AMERICAN JOURNAL OF PATHOLOGY., vol. 181, no. 5, 1 November 2012 (2012-11-01), pages 1585-1594, XP055254671, US ISSN: 0002-9440, DOI: 10.1016/j.ajpath.2012.08.005 (B1)